Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Use of modified oligo-β-(1,3)-glucans for treating diseases of the immune system, oligo-β-(1,3)-glucan-(1,3)-mannose, oligo-β-(1,3)-glucan-(1,3)-mannitol and derivatives thereof, methods for preparing them and medicaments containing them

US Patent 8367641 · Granted Feb 5, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →